Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harin Bio is a South Korean biotechnology company that leverages a proprietary microbial fermentation platform to develop innovative bio-materials and health functional foods. The company is distinguished by its patented technology for producing water-soluble Bio-Sulfur through microbial synthesis, which is utilized in dermo-cosmetics to treat conditions such as acne and atopic dermatitis. Additionally, Harin Bio focuses on microbiome research, applying fermentation processes to natural ingredients like black ginger to enhance their bioavailability for metabolic health indications, specifically targeting obesity and diabetes. The company operates integrated R&D and manufacturing facilities in the Jeonnam region, providing both proprietary branded products and OEM/ODM services for the global healthcare and wellness markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harin Bio.